Preparation method and application of hybridoma cell secreting anti-TrxA protein monoclonal antibody
By preparing anti-TrxA protein monoclonal antibody hybridoma cells, the detection and purification of recombinant protein expression in pET-32a vector was solved, and high sensitivity and high accuracy detection and purification of TrxA tag recombinant protein were achieved, thereby improving the recombinant protein Soluble expression and purification efficiency.
Patent Information
- Application Number
- CN202410903136.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-08
- Publication Date
- 2024-11-01
AI Technical Summary
The existing technology is difficult to effectively detect and purify recombinant proteins expressed using pET-32a vector, especially due to the high temperature stability and prosolubilization efficiency of TrxA protein, which leads to challenges in soluble expression and purification of recombinant proteins.
By preparing anti-TrxA protein monoclonal antibody hybridoma cells, cell lines that can stably secrete TrxA monoclonal antibodies are obtained by screening and subcloning technology of the indirect ELISA method to specifically recognize and purify recombinant proteins carrying TrxA tags.
High sensitivity and high accuracy detection and purification of TrxA-tagged recombinant proteins are achieved, ensuring the soluble expression and purification efficiency of recombinant proteins.
Smart Images

Figure CN118879640A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to a method for preparing a hybridoma cell and an application thereof, and more specifically, to a method for preparing a hybridoma cell that secretes an anti-TrxA protein monoclonal antibody and an application thereof, and belongs to the field of biotechnology. Background Art
[0002] The prokaryotic expression system is well understood in both genetics and biochemistry as well as in molecular biology. Secondly, the genetic map of E. coli is clear, the operation is simple and easy to culture, the growth cycle is short and the cost is low. In addition, the E. coli expression system is also a safe genetic engineering experimental system with a variety of applicable host strains and different types of vector systems. Most importantly, E. coli has a strong tolerance to many proteins and can express exogenous proteins at high levels, thereby producing a large amount of target proteins.
[0003] pET-32a(+) is a commonly used translation vector for expressing soluble and functionally active proteins. The pET-32a(+) vector has an N-terminal thrombin cleavage site and an N-terminal enterokinase cleavage site. The C-terminus contains a 6×His tag, and the N-terminus contains a 6×His tag, a TrxA site, an Ek site, and an S tag. The pET vector system is a system that can effectively clone and express recombinant proteins in Escherichia coli. The pET vector system has provided a variety of commercial vector plasmids that can meet the needs of various applications and is the most widely used system for prokaryotic expression today.
[0004] Thioredoxins are a series of oxidoreductases widely present in organisms, which can reduce the binding of disulfide bonds by replacing thiodisulfide. Thioredoxin A (TrxA), which is often used as a fusion expression tag, has a weight of 11.6kDa. The most unique advantage of the TrxA tag is its thermal stability. TrxA itself is not used as an affinity tag to optimize recombinant proteins, but the recombinant protein is preserved by denaturing and removing impurities under high temperature conditions. TrxA has excellent solubilization efficiency. When used as a solubilization tag, it can increase the soluble expression of recombinant proteins from 12% to 95%. Summary of the invention
[0005] The object of the present invention is to provide a method for preparing a hybridoma cell secreting an anti-TrxA protein monoclonal antibody and its application, which has the technical characteristics of high sensitivity and can be used for the detection and purification of recombinant proteins expressed by a pET-32a(+) vector.
[0006] In order to achieve the above object, the present invention is implemented by the following technical solutions:
[0007] A method for preparing hybridoma cells that secrete anti-TrxA protein monoclonal antibodies, the preparation method comprising the following steps:
[0008] Step 1) Preparation of antigen: Prokaryotic expression of pET-32a empty vector to prepare TrxA protein;
[0009] Step 2) Immunization: TrxA antigen protein and Freund's complete adjuvant were mixed and emulsified at a ratio of 1:1, and then subcutaneously injected into 5 female BALB / c mice aged 6-8 weeks, with an antigen vaccination dose of 100 μg per mouse; wherein, three normal immunizations were performed, each with an interval of two weeks, except that Freund's complete adjuvant was used for the first immunization, and Freund's incomplete adjuvant was used for the other two immunizations; and one booster immunization was performed without Freund's adjuvant;
[0010] Step 3) Immune serum titer determination: The immune serum titer was determined by indirect ELISA method;
[0011] Step 4) boosting immunization: the mouse with the highest serum titer was selected and injected with 100 μg TrxA antigen protein at multiple points subcutaneously 3 days before fusion;
[0012] Step 5) Preparation of hybridoma: Aseptically remove the spleen of mice, prepare a spleen cell suspension and mix it with the mouse myeloma cell line SP2 / 0 in the logarithmic growth phase at a ratio of 10:1-5:1, centrifuge at 1000g for 7 minutes at room temperature, and discard the supernatant;
[0013] Step 6) Gently tap the bottom of the centrifuge tube to loosen the precipitate, slowly and evenly add polyethylene glycol preheated at 37°C into the centrifuge tube while shaking, and let it stand in a 37°C water bath for 1 min;
[0014] Step 7) Add 37°C preheated RPMI-1640 culture medium, add 10 mL of preheated RPMI-1640 culture medium within 3 minutes, and add the liquid dropwise while gently shaking the centrifuge tube during the whole process. Place the 50 mL centrifuge tube in a 37°C water bath and let it stand for 10 minutes;
[0015] Step 8) Centrifuge at 1000g for 5 min at room temperature, discard the supernatant, add HAT culture medium to resuspend the cells, and observe the cell fusion after three days of culture. Replace half of the HAT culture medium until clones are formed. Replace the HT culture medium seven days after fusion;
[0016] Step 9) The hybridoma cells secreting the monoclonal antibody of TrxA protein were screened by indirect ELISA method, and the positive clone hybridoma cells with higher titer were selected for subcloning, and cloned continuously 2-3 times by limiting dilution method until the cell positive rate reached 100%, thereby obtaining the hybridoma cell line secreting the anti-TrxA protein monoclonal antibody.
[0017] Preferably, the indirect ELISA method comprises the following steps:
[0018] Coating: Dissolve 50 μg of TrxA antigen protein in 10 mL of 0.05 M pH 9.6 phosphate buffer and coat a polystyrene 96-well plate at 100 μl / well at 4°C overnight.
[0019] Blocking: add 300 μL blocking solution (5% skim milk powder dissolved in PBS) to each well and incubate at 37°C for 2 h;
[0020] Primary antibody: 10 days after the third immunization, blood was collected from the tail vein of mice, and the mouse immune serum was graded diluted with 10 mM PBS and added to a 96-well plate, 100 μL per well, incubated at 37°C for 1 h;
[0021] Washing: Wash the plate three times with PBS (containing 0.05% (V / V) Tween-20) and pat dry;
[0022] Secondary antibody: add 1:3000 dilution of horseradish peroxidase-labeled goat anti-mouse IgG, add 100 μL to each well, incubate at 37°C for 1 h;
[0023] Washing: Wash the plate four times with PBST and pat dry;
[0024] Color development: add 100 μL TMB to each well for color development, incubate at 37°C in the dark for 15 min;
[0025] Termination: Add 50 μL 2M H2SO4 to each well to terminate the reaction;
[0026] Reading: Read the absorbance at 450nm.
[0027] Preferably, step 1) specifically includes: inducing expression of TrxA protein, identifying expression of TrxA protein, and purifying TrxA protein;
[0028] Inducible expression of TrxA protein:
[0029] Take pET-32a glycerol bacteria and inoculate them into liquid LB medium containing Amp resistance at a volume ratio of 1:100, activate them in a shaking incubator at 37°C and 220 rpm for 12 to 16 hours, and extract the pET-32a plasmid;
[0030] Use pET-32a plasmid to transform Rosetta competent cells, and after screening on coated plates, the correctly identified strains will be subjected to bacterial preservation operations;
[0031] The strain obtained above was inoculated into liquid LB medium containing Amp resistance at a volume ratio of 1:100, and activated at 37°C, 220 rpm on a shaker for 12 to 16 h. Then the activated bacterial solution was inoculated into liquid LB medium containing Amp for expansion culture for 3 to 4 h until the OD of the bacterial solution reached 600 When the value reaches 0.6-0.8, add IPTG to a final concentration of 1.0 mM, induce expression at 16°C, 220 rpm for 12-16 h, and obtain induced bacteria;
[0032] Expression and identification of TrxA protein:
[0033] Collect bacteria: collect induced bacteria and centrifuge at room temperature at 6000 rpm for 20 min;
[0034] Washing the cells: Add sterile PBS solution to the cells and repeatedly blow to resuspend the cells. Centrifuge at 4°C, 12,000 rpm for 20 min and discard the supernatant.
[0035] Ultrasonic disruption: add sterile PBS buffer to resuspend the cells, and use an ultrasonic disruptor to perform ultrasonic disruption on ice for 20 min, setting the instrument frequency to 60%, and resting for 5 s after every 3 s of ultrasonication;
[0036] Separation of supernatant and precipitate: After complete ultrasonic disruption, the bacterial suspension was centrifuged at 4°C, 12000rpm for 15min, and the supernatant and precipitate were collected separately. The precipitate was resuspended in sterile PBS buffer and then sampled and analyzed by SDS-PAGE electrophoresis together with the bacterial suspension samples before and after induction.
[0037] Purification of TrxA protein:
[0038] Sample processing: collect the supernatant after bacterial cell disruption and filter through a 0.45 μm filter membrane to remove impurities;
[0039] Balance: After the 20% ethanol protective solution in the column flows out, add 2 times the column volume of balance solution, repeat 3 times to completely remove the protective solution;
[0040] Loading: Add the treated protein sample to the nickel column and incubate it on a 4°C rotating binder for 3 hours to allow the target protein to fully bind to the nickel filler. Open the lid at the bottom of the purification column and allow the liquid in the column to flow out under gravity. Collect the flow-through for subsequent analysis and detection.
[0041] Washing: Add 6 column volumes of 25 mM imidazole washing solution, incubate at 4°C for 15 min, then drain the liquid. Repeat 3 times to ensure that the impurities are washed away. Collect the washing solution each time for subsequent analysis and detection.
[0042] Elution: Add 1 to 2 column volumes of 250 mM imidazole eluent to elute the target protein, incubate at 4°C for 20 min, and allow it to slowly flow through the nickel column. Repeat 3 times, collecting the eluate into a different centrifuge tube each time, and collecting the eluate each time for subsequent analysis and detection;
[0043] Cleaning and preservation of the column: add 5 times column volume of 500mM imidazole washing solution to wash three times, drain the washing solution, fill the nickel column with 20% ethanol preservation solution, and store it at 4°C to obtain the purified TrxA protein.
[0044] The invention discloses a monoclonal antibody, which is obtained from the hybridoma cell line.
[0045] The invention discloses an application of a monoclonal antibody for detecting and purifying a recombinant protein containing a TrxA tag.
[0046] The invention discloses an application of a monoclonal antibody for detecting and purifying a recombinant protein prepared by pET-32a(+).
[0047] Beneficial effects: The anti-TrxA monoclonal antibody hybridoma cell line of the present invention can stably secrete TrxA monoclonal antibodies; the TrxA monoclonal antibodies provided by the present invention can specifically identify recombinant proteins carrying TrxA tags with high sensitivity and accuracy. BRIEF DESCRIPTION OF THE DRAWINGS
[0048] Figure 1 This is a diagram for identifying the induced expression of the TrxA protein of the present invention.
[0049] Figure 2 This is a diagram of the purification and identification of the TrxA protein of the present invention.
[0050] Figure 3 This is a diagram showing the results of cell fusion according to the present invention.
[0051] Figure 4 It is a picture of hybridoma cell colony of the present invention.
[0052] Figure 5 This is a diagram of Western blotting validation of the TrxA monoclonal antibody of the present invention. DETAILED DESCRIPTION
[0053] The following is in conjunction with the instruction manual Figure 1-5 , the present invention is further illustrated, but the present invention is not limited to the following embodiments.
[0054] An example of a hybridoma cell for preparing monoclonal antibodies against TrxA protein:
[0055] 1. Experimental Materials
[0056] SPF female BALB / c mice aged 6-8 weeks were purchased from Shanghai Slake Laboratory Animal Co., Ltd.; SP2 / 0 myeloma cells were purchased from the Cell Bank of Type Culture Collection Committee of the Chinese Academy of Sciences; vector pET-32a and E. coli Rosetta strain were preserved by our laboratory.
[0057] 2. Test methods
[0058] 2.1 Inducible expression of TrxA protein
[0059] Take pET-32a glycerol bacteria and inoculate them into liquid LB medium containing Amp resistance at a volume ratio of 1:100, and activate them in a shaking table at 37°C and 220 rpm for 12 to 16 hours. Extract the pET-32a plasmid according to the instructions of the plasmid mini-extraction kit.
[0060] Take an appropriate amount of pET-32a plasmid to transform Rosetta competent cells. After screening on coated plates, the correctly identified strains will be subjected to bacterial preservation operations.
[0061] The glycerol bacteria obtained above were inoculated into the liquid LB medium containing Amp resistance at a volume ratio of 1:100, and activated on a shaker at 37°C and 220 rpm for 12 to 16 hours. The activated bacterial solution was then inoculated into the liquid LB medium containing Amp for expansion culture for 3 to 4 hours until the OD of the bacterial solution reached 600 When the value reached 0.6-0.8, IPTG was added to a final concentration of 1.0 mM, and the expression was induced at 16°C and 220 rpm for 12-16 h.
[0062] 2.2 Expression and identification of TrxA protein
[0063] (1) Collecting bacteria: Collect the induced bacteria and centrifuge at 6000 rpm for 20 min at room temperature;
[0064] (2) Washing the cells: Add sterile PBS solution to the cells and repeatedly pipette to resuspend the cells. Centrifuge at 4°C, 12,000 rpm for 20 min and discard the supernatant.
[0065] (3) Ultrasonic disruption: Add sterile PBS buffer to resuspend the cells, and use an ultrasonic disruptor to perform ultrasonic disruption on ice for 20 min. Set the instrument frequency to 60%, and rest for 5 s after every 3 s of ultrasonication.
[0066] (4) Separation of supernatant and precipitate: After complete ultrasonic disruption of the bacterial suspension, centrifuge at 4°C, 12,000 rpm for 15 min. Collect the supernatant and precipitate separately. After the precipitate is resuspended in sterile PBS buffer, take samples and perform SDS-PAGE electrophoresis analysis and identification together with the bacterial suspension samples before and after induction.
[0067] 2.3 Purification of TrxA protein
[0068] (1) Sample processing: collect the supernatant after bacterial cell disruption and filter through a 0.45 μm filter membrane to remove impurities;
[0069] (2) Equilibration: After the 20% ethanol protective solution in the column flows out, add equilibration solution of 2 times the column volume, and repeat 3 times to completely remove the protective solution;
[0070] (3) Sample loading: Add the treated protein sample to the nickel column and incubate it on a 4°C rotating binder for 3 h.
[0071] The target protein is fully combined with the nickel filler, the lid at the bottom of the purification column is opened, the liquid in the column flows out under the action of gravity, and the flow-through liquid is collected for subsequent analysis and detection;
[0072] (4) Washing: Add 6 column volumes of 25 mM imidazole washing solution, incubate at 4°C for 15 min, and then drain the liquid. Repeat 3 times to ensure that impurities are washed away. Collect the washing solution each time for subsequent analysis and detection;
[0073] (5) Elution: Add 1 to 2 column volumes of 250 mM imidazole eluent to elute the target protein, incubate at 4°C for 20 min, and allow it to slowly flow through the nickel column. Repeat 3 times, collecting the eluate into a different centrifuge tube each time, and collecting the eluate each time for subsequent analysis and detection;
[0074] (6) Column cleaning and storage: Add 5 times column volume of 500 mM imidazole washing solution and wash three times. Drain the washing solution, fill the nickel column with 20% ethanol storage solution, and store at 4°C.
[0075] 2.4 Immunization of mice
[0076] Emulsify the above-prepared protein with an equal volume of Freund's complete adjuvant. After sufficient emulsification, 6-8 week-old BALB / c mice are immunized by subcutaneous multi-point injection. Immunization is performed once every 2 weeks, for a total of 3 times. Starting from the second immunization, Freund's incomplete adjuvant is used instead of complete adjuvant for emulsification at a ratio of 1:1. The third immunization scheme is the same as the second. The antigen vaccination dose for each mouse is 100 μg each time.
[0077] 2.5 Immune serum titer determination
[0078] The serum antibody titer level was detected by indirect ELISA method 7-10 days after the third immunization. The mice with the highest antibody titer were selected for booster immunization by subcutaneous injection of 100 μg TrxA protein.
[0079] 2.6 Preparation of myeloma cells
[0080] SP2 / 0 cell line was revived by conventional cell resuscitation method, cultured in a 37°C, 5% CO2 cell culture incubator, confirmed that the cells were in the vigorous growth period, expanded culture 3 days before fusion, and collected into centrifuge tubes on the day of fusion. The cells were washed 3 times with RPMI-1640 medium preheated at 37°C and resuspended, and 2-5×10 6 cells / mouse and wait for cell fusion.
[0081] 2.7 Preparation of trophoblast cells
[0082] Normal mouse peritoneal macrophages were used as trophoblast cells, and feeder cells were prepared one day before fusion. The preparation steps of mouse peritoneal macrophages were as follows:
[0083] (1) 6-week-old healthy BALB / c mice were killed by cervical dislocation and their body surfaces were disinfected with 75% alcohol;
[0084] (2) Fix the mouse on a foam board, expose the peritoneum by blunt dissection, inject preheated RPMI-1640 culture medium into the mouse abdomen with a disposable syringe, and gently massage the mouse abdomen with the fingertips to allow the macrophages in the peritoneal cavity to be fully mixed into the culture medium. Draw out the cell fluid in the peritoneal cavity with a syringe and inject it into a centrifuge tube. Repeat the operation of taking peritoneal macrophages 3 times, centrifuge at 1000 rpm / min for 7 minutes, discard the supernatant, and add HAT selection culture medium containing 20% fetal bovine serum to resuspend the cells;
[0085] (3) Count the cells at 1 to 2 × 10 6 Add the culture medium at a density of 100 μL / mL into a 96-well cell culture plate, add 100 μL to each well, observe the cells after 24 hours, and use them if there is no contamination.
[0086] 2.8 Preparation of splenocytes
[0087] Blood was collected from the eyeballs of BALB / c mice in the immunized group, and the mice were killed by cervical dislocation and immersed in 75% alcohol for disinfection. The mice were fixed on a sterile foam board, and the spleen was carefully removed. The spleen was crushed and ground with a disposable syringe without a needle to fully release the spleen cells. The spleen cell suspension was then passed through a 70μm cell filter twice, centrifuged at 1000r / min for 10min, and the supernatant was discarded. The spleen cells were washed 2 to 3 times with preheated RPMI-1640 medium, and the cells were resuspended and counted with a cell counting plate for later use.
[0088] 2.9 Cell fusion
[0089] (1) Splenocytes and SP2 / 0 cells were mixed at a ratio of 10:1 to 5:1, and the mixture was placed in a centrifuge tube. The mixture was centrifuged at 1000 r / min for 10 min, the supernatant was discarded, and the tube was washed twice with preheated RPMI-1640 medium to ensure that the splenocytes and SP2 / 0 cells were evenly mixed. All the supernatant was discarded, and the bottom of the tube was gently tapped to loosen the cells and mix them evenly;
[0090] (2) Pipette 1 mL of PEG preheated at 37°C and slowly drip PEG into the centrifuge tube while gently shaking it. Make sure that the PEG is dripped in 1 min. Immediately place the centrifuge tube in a 37°C water bath for 1 min.
[0091] (3) Add 1 mL of 37°C preheated RPMI-1640 culture medium within 45 seconds, add RPMI-1640 culture medium dropwise while rotating the centrifuge tube, add 2 mL of preheated RPMI-1640 culture medium within 1 minute, add 10 mL of preheated RPMI-1640 culture medium within 3 minutes, and place the centrifuge tube in a 37°C water bath for 10 minutes;
[0092] (4) Gently remove the centrifuge tube, centrifuge at 1000 rpm for 10 min, discard the supernatant, resuspend the cells in HAT selection medium, and then add 100 μL per well to the culture plate containing trophoblast cells;
[0093] (5) After 24 hours, observe whether there is contamination. If there is no contamination, immediately return the cells to the incubator for further culture. After 5 to 7 days, half of the medium is replaced with HAT selection medium containing 20% fetal bovine serum. After 10 days after fusion, the medium is fully replaced with HAT selection medium. After 14 days after fusion, the medium is fully replaced with HT selection medium.
[0094] 2.10 Screening of positive hybridoma cells
[0095] When the hybridoma cell colony occupies about 1 / 5 of the cell well area, the ELISA plate is coated with purified TrxA protein at 5 μg / mL and placed at 4°C overnight. 100 μL of cell culture supernatant is taken as the primary antibody for ELISA detection, and SP2 / 0 cell culture supernatant and normal mouse serum are set as negative controls. The ELISA detection judgment criteria are: the OD value of the negative well is less than 0.1, P / N>2.1, which is a positive hybridoma cell well.
[0096] 2.11 Subcloning of positive hybridoma cells
[0097] Hybridoma cell subcloning uses the limiting dilution method, the steps of which are:
[0098] (1) Prepare trophoblast cells one day before subcloning, resuspend peritoneal macrophages in HT selection medium containing 20% fetal bovine serum, and plate 100 μL per well in a 96-well cell culture plate;
[0099] (2) Take the positive hybridoma cell suspension, add 200 μL of HT selection medium containing 20% fetal bovine serum, and add it to well A1 of the 96-well plate. Then use a pipette to transfer 100 μL from well A1 to well B1 and mix gently. Repeat the 1:2 dilution throughout the column until well H1. Discard 100 μL of cell suspension and finally make the volume of all wells the same.
[0100] (3) Use an 8-channel pipette to add 100 μL of HT selection medium containing 20% fetal bovine serum to all wells except the first column, then add an additional 100 μL of HT selection medium containing 20% fetal bovine serum to each well in the first column, mix gently, and then use a pipette to draw 100 μL of the suspension from the first column (A1 to H1), quickly transfer it to the second column (A2 to H2), and mix gently;
[0101] (4) Repeat the 2-fold dilution in the same way throughout the 96-well plate, pipette and discard 100 μL of the suspension from the last column (A12 to H12) to make the final volume in all wells 200 μL / well;
[0102] (5) Place the subcloned cell plate in a cell culture incubator for culture. After the cell clones are formed, use the indirect ELISA method to detect the supernatant in the cell culture wells. The cell culture wells that are detected positive need to be subcloned 2 to 3 times until the last subclone ELISA result shows a positive rate of 100%, which proves that the hybridoma cell line that can stably secrete monoclonal antibodies has been successfully established.
[0103] 2.12 Cryopreservation of Positive Hybridoma Cells
[0104] According to the steps, a cell line that stably secretes anti-TrxA monoclonal antibodies is finally obtained, and cells with a positive rate of 100% after cloning are expanded and cultured and then frozen in liquid nitrogen.
[0105] Test conclusion:
[0106] Combined with Figure 1-5 As is known, the monoclonal antibody secreted by the hybridoma cell line provided by the present invention has good specificity and can react with the TrxA protein expressed by the pET-32a vector.
[0107] The invention discloses a monoclonal antibody, which is obtained from the hybridoma cell line.
[0108] The invention discloses an application of a monoclonal antibody for detecting and purifying a recombinant protein containing a TrxA tag.
[0109] The invention discloses an application of a monoclonal antibody for detecting and purifying a recombinant protein prepared by pET-32a(+).
[0110] Finally, it should be noted that the present invention is not limited to the above embodiments, and there are many variations. All variations that can be directly derived or associated with the content disclosed by ordinary technicians in this field should be considered as the protection scope of the present invention.
Claims
1. A method for preparing hybridoma cells secreting anti-TrxA protein monoclonal antibodies, Features The preparation method comprises the following steps: Step 1) Preparation of antigen: Prokaryotic expression of pET-32a empty vector to prepare TrxA protein; Step 2) Immunization: TrxA antigen protein and Freund's complete adjuvant were mixed and emulsified at a ratio of 1:1, and then subcutaneously injected into 5 female BALB / c mice aged 6-8 weeks, with an antigen vaccination dose of 100 μg per mouse; wherein, three normal immunizations were performed, each with an interval of two weeks, except that Freund's complete adjuvant was used for the first immunization, and Freund's incomplete adjuvant was used for the other two immunizations; and one booster immunization was performed without Freund's adjuvant; Step 3) Immune serum titer determination: The immune serum titer was determined by indirect ELISA method; Step 4) Enhanced immunization: Take the mouse with the highest serum titer and inject 100 μg TrxA antigen protein subcutaneously at multiple points 3 days before fusion. Step 5) Preparation of hybridoma: Aseptically remove the spleen of mice, prepare a spleen cell suspension and mix it with the mouse myeloma cell line SP2 / 0 in the logarithmic growth phase at a ratio of 10:1-5:1, centrifuge at 1000g for 7 minutes at room temperature, and discard the supernatant; Step 6) Gently tap the bottom of the centrifuge tube to loosen the precipitate, slowly and evenly add polyethylene glycol preheated at 37°C into the centrifuge tube while shaking, and let it stand in a 37°C water bath for 1 min; Step 7) Add 37°C preheated RPMI-1640 culture medium, add 10 mL of preheated RPMI-1640 culture medium within 3 minutes, and add the liquid dropwise while gently shaking the centrifuge tube during the whole process. Place the 50 mL centrifuge tube in a 37°C water bath and let it stand for 10 minutes; Step 8) Centrifuge at 1000g for 5 min at room temperature, discard the supernatant, add HAT culture medium to resuspend the cells, and observe the cell fusion after three days of culture. Replace half of the HAT culture medium until clones are formed. Replace the HT culture medium seven days after fusion; Step 9) The hybridoma cells secreting the monoclonal antibody of TrxA protein were screened by indirect ELISA method, and the positive clone hybridoma cells with higher titer were selected for subcloning, and cloned continuously 2-3 times by limiting dilution method until the cell positive rate reached 100%, thereby obtaining a cell line that stably secreted the anti-TrxA monoclonal antibody.
2. The method for preparing a hybridoma cell secreting an anti-TrxA protein monoclonal antibody according to claim 1, Features: The indirect ELISA method comprises the following steps: Coating: Dissolve 50 μg of TrxA antigen protein in 10 mL of 0.05 M pH 9.6 phosphate buffer and coat a polystyrene 96-well plate at 100 μl / well at 4°C overnight. Blocking: Add 300 μL of blocking solution to each well and incubate at 37°C for 2 h; Primary antibody: 10 days after the third immunization, blood was collected from the tail vein of mice, and the mouse immune serum was graded diluted with 10 mM PBS and added to a 96-well plate, 100 μL per well, incubated at 37°C for 1 h; Washing: Wash the plate three times with PBS and pat dry; Secondary antibody: add 1:3000 dilution of horseradish peroxidase-labeled goat anti-mouse IgG, add 100 μL to each well, incubate at 37°C for 1 h; Washing: Wash the plate four times with PBST and pat dry; Color development: add 100 μL TMB to each well for color development, incubate at 37°C in the dark for 15 min; Stop: Add 50 μL 2M H 2 SO 4 Terminate the reaction; Reading: Read the absorbance at 450nm.
3. A monoclonal antibody, Features: The monoclonal antibody is obtained from the hybridoma cell line according to claim 1.
4. A use of the monoclonal antibody according to claim 3, Features: Used for detection and purification of recombinant proteins containing TrxA tags.
5. A use of the monoclonal antibody according to claim 3, Features: Used for detection and purification of recombinant proteins produced by pET-32a(+).
6. The method for preparing a hybridoma cell secreting an anti-TrxA protein monoclonal antibody according to claim 1, Features: Step 1) specifically includes: inducing expression of TrxA protein, identifying the expression of TrxA protein, and purifying TrxA protein; Inducible expression of TrxA protein: Take pET-32a glycerol bacteria and inoculate them into liquid LB medium containing Amp resistance at a volume ratio of 1:100, activate them in a shaking incubator at 37°C and 220 rpm for 12 to 16 hours, and extract the pET-32a plasmid; Use pET-32a plasmid to transform Rosetta competent cells, and after screening on coated plates, the correctly identified strains will be subjected to bacterial preservation operations; The strain obtained above was inoculated into liquid LB medium containing Amp resistance at a volume ratio of 1:100, and activated at 37°C, 220 rpm on a shaker for 12 to 16 h. Then the activated bacterial solution was inoculated into liquid LB medium containing Amp for expansion culture for 3 to 4 h until the OD of the bacterial solution reached 600 When the value reaches 0.6-0.8, add IPTG to a final concentration of 1.0 mM, induce expression at 16°C and 220 rpm for 12-16 h to obtain induced bacteria; Expression and identification of TrxA protein: Collect bacteria: collect induced bacteria and centrifuge at room temperature at 6000 rpm for 20 min; Washing the cells: Add sterile PBS solution to the cells and repeatedly blow to resuspend the cells. Centrifuge at 4°C, 12,000 rpm for 20 min and discard the supernatant. Ultrasonic disruption: add sterile PBS buffer to resuspend the cells, and use an ultrasonic disruptor to perform ultrasonic disruption on ice for 20 min, setting the instrument frequency to 60%, and resting for 5 s after every 3 s of ultrasonication; Separation of supernatant and precipitate: After complete ultrasonic disruption, the bacterial suspension was centrifuged at 4°C, 12000rpm for 15min, and the supernatant and precipitate were collected separately. The precipitate was resuspended in sterile PBS buffer and then sampled and analyzed by SDS-PAGE electrophoresis together with the bacterial suspension samples before and after induction. Purification of TrxA protein: Sample processing: collect the supernatant after bacterial cell disruption and filter through a 0.45 μm filter membrane to remove impurities; Balance: After the 20% ethanol protective solution in the column flows out, add 2 times the column volume of balance solution, repeat 3 times to completely remove the protective solution; Loading: Add the treated protein sample to the nickel column and incubate it on a 4°C rotating binder for 3 hours to allow the target protein to fully bind to the nickel filler. Open the lid at the bottom of the purification column and allow the liquid in the column to flow out under gravity. Collect the flow-through for subsequent analysis and detection. Washing: Add 6 column volumes of 25 mM imidazole washing solution, incubate at 4°C for 15 min, then drain the liquid. Repeat 3 times to ensure that the impurities are washed away. Collect the washing solution each time for subsequent analysis and detection. Elution: Add 1 to 2 column volumes of 250 mM imidazole eluent to elute the target protein, incubate at 4°C for 20 min, and allow it to slowly flow through the nickel column. Repeat 3 times, collecting the eluate into a different centrifuge tube each time, and collecting the eluate each time for subsequent analysis and detection; Cleaning and preservation of the column: add 5 times column volume of 500mM imidazole washing solution to wash three times, drain the washing solution, fill the nickel column with 20% ethanol preservation solution, and store it at 4°C to obtain the purified TrxA protein.
